SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001157523-10-003114
Filing Date
2010-05-13
Accepted
2010-05-13 08:35:29
Documents
6
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 OPEXA THERAPEUTICS, INC. 10-Q a6287565.htm 10-Q 431635
2 LOGO logo.jpg GRAPHIC 2173
3 EXHIBIT 4.1 a6287565ex41.htm EX-4.1 23097
4 EXHIBIT 4.2 a6287565ex42.htm EX-4.2 21242
5 EXHIBIT 31.1 a6287565ex311.htm EX-31.1 15707
6 EXHIBIT 32.1 a6287565ex321.htm EX-32.1 7380
  Complete submission text file 0001157523-10-003114.txt   503917
Mailing Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381
Business Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33004 | Film No.: 10826579
SIC: 2834 Pharmaceutical Preparations